Article info

Download PDFPDF

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Authors

  1. Correspondence to Dr Hermine I Brunner, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, PRCSG Coordinating Center, Cincinnati, Ohio, USA; Hermine.brunner{at}cchmc.org
View Full Text

Citation

Brunner HI, Abud-Mendoza C, Viola DO in collaboration with the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG), et al
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Publication history

  • Received February 4, 2020
  • Revised May 29, 2020
  • Accepted June 8, 2020
  • First published July 22, 2020.
Online issue publication 
September 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.